| 0.0125 Data as of Jun 17 |  +0.0037 / +42.05%Today’s Change | 0.00 Today|||52-Week Range 0.02 | +25.00% Year-to-Date |
| Previous close | 0.01 |
| Today’s open | 0.01 |
| Day’s range | 0.01 - 0.01 |
| Volume | 15,000 |
| Average volume (3 months) | 29,482 |
| Market cap | $472.0K |
| Dividend yield | -- |
| Earnings growth (last year) | +6.67% |
| Earnings growth (this year) | +1.43% |
| Earnings growth (next 5 years) | +40.00% |
| Revenue growth (last year) | -36.62% |
| P/E ratio | NM |
| Price/Sales | 233.25 |
| Price/Book | -- |
| No competitors data available. |
| Last reporting date | March 4, 2009 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $180.0K |
| Annual profit (last year) | -$37.5M |
| Net profit margin | -20,810.56% |
Sector Health Technology |
Industry Biotechnology |
President & Chief Executive Officer John R. Barr, MBA |
Chief Financial Officer Thomas T. Higgins |
Corporate headquarters Watertown, Massachusetts |
.
